Demand For Bulk Drugs Pharmaceutical Enterprise Performance Surge Of Warmer
Wind, according to statistics, as of April 15
, 12 Pharmaceutical Industry Notice issued in the first quarter is forecasted to go. Most of these pharmaceutical companies in the chemical distribution Pharmacy And Traditional Chinese medicine Two sub-sectors.
Data show that from January to February 2010, the pharmaceutical industry realized profits of 15.9 billion yuan, up 40.4%, an increase by 18 percentage points. Analysts said that as the follow-up to the pharmaceutical industry remains robust, the pharmaceutical industry is expected this year the total amount of revenue and profit growth will be more than 30%, 45%, of which chemical API And Chinese medicine industry will increase by a relatively significant.
Demand for warmer API As of now, there are six classes of chemical pharmaceutical companies report released in the first quarter is forecasted to go. Among them, four companies in the first quarter rose by more than 600% results.
Lukang Pharmaceutical [8.043.34%] (600,789) Net income for the quarter is expected to more than 45 million yuan, increasing 800% over pre; days of Mao Group [6.272.79%] (000 627) is expected in the first quarter net profit -3000 million to 29 million yuan, an increase of 750% -800%. Southwest synthesis [13.47-0.66%] (000 788) is expected in the first quarter net profit of about 19 million yuan -2 100 yuan, an increase of 647.5% -726.2%.
Addition, Haixiang Pharmaceutical [16.756.21%] (002099), Zhejiang Medicine [37.970.42%] (600 216), new, and into [49.10-2.09%] (002 001) is expected to increase by a quarter by 300% -350%, 150% -200%, 70% -100%. Among them, new, and into that since the first quarter of last year Financial Crisis led to Vitamin Sluggish market demand, the company leading product VE, VA sales have fallen sharply, while the first quarter of this year, market recovered, sales increased significantly.
Researcher Liang Liang said the first venture, chemical drugs, bulk drug has been out of the financial crisis, the performance of the chemical drug preparations will remain fairly level with the industry.
The first quarter of this year, the pharmaceutical industry to achieve Sell Income of 143.018 billion yuan, up 28%; profit amounted to 14.751 billion yuan, up 43.2%. Gross margin reached 32.3% of the pharmaceutical industry, to its highest point since 2006.
Addition, Fosun [23.381.83%] (600 196) is expected to achieve first quarter of 2010 net profit attributable to shareholders increased over the same period in 2009, more than 80%.
Remarkable growth of Chinese medicine
Chinese listed companies, only purple Xin Pharmaceutical [15.24-0.46%] posted a quarterly, the Company realized operating income of 32,096,800 yuan, up 16.1%; net profit of 11.7136 million yuan, up 108.78 percent; basic Earnings per share 0.06 yuan. Company said this year's transformation of domestic investment in equipment can be income tax credit contribution of 5.517 million yuan on higher net profit.
Demand For Bulk Drugs Pharmaceutical Enterprise Performance Surge Of Warmer
By: zhangbetty
Vital Questions To Ask Before Choosing A Medical Spa Aarkstore Enterprise---ats Medical, Inc. (atsi) - Financial And Strategic Analysis Review Aarkstore Enterprise---inverness Medical Innovations, Inc. (ima) - Financial And Strategic Analysis Medical Billing Software What You Need To Know About Mold Remediation The Maryland Drug Treatment Centers Is There Anything I Can Do When The Prescription Drug Plavix Causes Me To Bruise Easily? Psoriasis Drugs Mold Remediation San Francisco: Freedom From Fungi Medical Hair Restoration Cost Medical Hair Transplant Choosing A Career In Medicine What You Want To Apprehend About Acid Reflux Medicines